“SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa

Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89%...

Descripción completa

Detalles Bibliográficos
Autores principales: Sossen, Bianca, Broger, Tobias, Kerkhoff, Andrew D, Schutz, Charlotte, Trollip, Andre, Moreau, Emmanuel, Schumacher, Samuel G, Burton, Rosie, Ward, Amy, Wilkinson, Robert J, Barr, David A, Nicol, Mark P, Denkinger, Claudia M, Meintjes, Graeme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240995/
https://www.ncbi.nlm.nih.gov/pubmed/31917832
http://dx.doi.org/10.1093/cid/ciaa024
Descripción
Sumario:Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86–97%.

Ejemplares similares